Location History:
- Rockville, MD (US) (1996 - 2000)
- Bethesda, MD (US) (2004 - 2017)
Company Filing History:
3 out of 1,217 
2 out of 21 
1 out of 8 Years Active: 1996-2017
Title: Innovations by Rene Etcheberrigaray
Introduction
Rene Etcheberrigaray is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of cognitive enhancement and Alzheimer's disease treatment. With a total of six patents to his name, his work focuses on innovative methods to improve cognitive abilities in individuals suffering from Alzheimer's disease.
Latest Patents
Among his latest patents are methods for Alzheimer's disease treatment and cognitive enhancement. These inventions relate to compositions and methods that modulate α-secretase and improve cognitive ability. The inventions specifically address enhanced cognitive ability in diseased individuals, particularly Alzheimer's disease patients, through increased sAPP production. Macrocyclic lactones, such as bryostatin and neristatin classes, are preferred compounds for use in these compositions. Additionally, the inventions provide methods for increasing the generation of non-amyloidogenic soluble APP by activating protein kinase C (PKC) through the administration of effective amounts of PKC activators.
Career Highlights
Rene has worked with prominent organizations, including the United States of America as represented by the Department of Health and the Blanchette Rockefeller Neurosciences Institute. His work has been instrumental in advancing research and treatment options for cognitive impairments.
Collaborations
Rene has collaborated with notable individuals in his field, including Daniel L. Alkon and Christopher S. Kim. These collaborations have contributed to the development of innovative solutions for cognitive enhancement.
Conclusion
Rene Etcheberrigaray's contributions to the field of cognitive enhancement and Alzheimer's disease treatment through his patents highlight his dedication to improving the lives of individuals affected by these conditions. His innovative methods and collaborations continue to pave the way for advancements in this critical area of research.